Qualifying for GLP-1 Weight Loss: Whos a Good Candidate
doi: 10.3389/fphar.2025.1710088 Received 21 September 2025 Revised 17 November 2025 Accepted 25 November 2025 Published 05 January 2026 Volume 16 - 2025 Edited by Sidharth Prasad Mishra, University of South Florida, United States Reviewed by Abdullah Shaito, Qatar University, Qatar Cosmin Mihai Vesa, University of Oradea, Romania Raquel de Cssia dos Santos, Sao Francisco University, Brazil Shengqian Sun, Yantai Institute of Technology, China Updates Copyright 2026 Rudrapal, de Oliveira and Singh
A 2025 article from SHRM reports a notable increase in the average representation of GLP-1 drugs used for weight loss in total annual claims for employers, increasing from 8.9 percent in 2024 to 10.5 percent in 2025
Remember, wearing a mask or cloth face covering is not a substitute for social distancing